Merimepodib

Merimepodib is an inosine monophosphate dehydrogenase (IMPDH) inhibitor with activity against hepatitis C virus (HCV). IMPDH catalyzes the rate-limiting step in the de novo synthesis of guanine nucleotides, and treatment with merimepodib reduces the intracellular guanine nucleotide levels that are required for RNA and DNA synthesis, resulting in antiproliferative and antiviral effect. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Merimepodibum and DTXSID70173639. Its PubChem CID is 153241.

CAS No 198821-22-6
Molecular Formula C23H24N4O6
Molecular Weight 452.50 g/mol
Synonyms [(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate

Frequently Asked Questions